Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs PEGA✓SelectedUSD · PEGAGSK vs PEGA performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs PEGA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+43.0%
PEGA return
-48.4%
Excess return
+91.4%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioPEGAExcessAlpha
1D-2.3%-5.2%+2.8%-2.2%
7D-3.0%-2.9%-0.2%-2.9%
30D+0.4%-11.3%+11.7%+0.6%
3M-1.2%-3.8%+2.6%-1.1%
6M+0.9%-8.7%+9.7%+1.0%
YTD+4.0%-48.4%+52.4%+5.4%
1Y+7.3%-43.6%+50.9%+8.4%
3Y+57.1%+20.6%+36.5%+54.2%
5Y+43.0%-47.0%+90.0%+41.1%
All+43.0%-48.4%+91.4%+41.1%

Cumulative growth

Daily Returns

Daily percentage return beside PEGA.

Daily Out/Under-Performance

Portfolio return minus PEGA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × PEGA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded PEGA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling